EyePoint Pharmaceuticals Inc

NASDAQ:EYPT   1:42:00 PM EDT
8.62
-0.19 (-2.16%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)292.15M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.79 Million
Adjusted EPS-$0.53
See more estimates
10-Day MA$9.41
50-Day MA$13.27
200-Day MA$10.89
See more pivots

EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT

480 Pleasant Street, Suite B300, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.926.5000
Number of Employees: 101

Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.